| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |